Skip to content
Screener

Alamar Biosciences ALMR Shares (Diluted)

Shares (Diluted) at other companies

Veradermics logo
VeradermicsMANE
22.7M+2,981%
GPA
General Purpose Acquisition Corp.GPAC
9.9M+87.1%
BK
BKBK
698.2M-4.0%
Schering-Plough logo
Schering-PloughSGP
19.9M+794%
Dycom Industries logo
Dycom IndustriesDY
30.4M+3.8%
Target logo
TargetTGT
455.8M-0.2%

Other financials

Income statement

See full
Revenue$26.0M+98.9%
Gross profit$14.5M+126%
Operating income-$12.3M-44.4%
Net income-$21.3M-178%
EPS (diluted)-$1.74-156%

Balance sheet

See full
Cash & equivalents$64.6M—
Total debt$30.6M—
Total equity-$178.1M—
Total assets$186.5M—

Cash flow

See full
Operating cash flow-$20.3M-55.7%
CapEx$600.0K+8.3%
Free cash flow-$20.9M-53.8%

Valuation

See full
Market cap$1.96B+37.6%
Enterprise value$1.93B—

Returns & leverage

See full
Debt / equity-0.2×—
Current ratio5.9×—

Where this comes from

Reported directly by Alamar Biosciences in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Alamar Biosciences’s 10-Q, filed May 8, 2026. Open the filing →

Filed
May 8, 2026, 8:30 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-213424

FAQ

What is Alamar Biosciences's shares (diluted)?
Alamar Biosciences (ALMR) reported shares (diluted) of 12.3M in Q1 2026.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Alamar Biosciences's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude